SCHEMBL16982014

SCHEMBL16982014

CC(C)CC(c1ccc(C(C)C)cc1)N1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
TSHR P16473 1/20 0.42
HRH3 Q9Y5N1 2/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
SLC6A2 P23975 6/20 0.41
SLC6A3 Q01959 6/20 0.41
SLC6A4 P31645 5/20 0.41
HPGD P15428 2/20 0.41
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TP53 P04637 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP2C9 P11712 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6789003 0.89 TP53 (0.48) CYP3A4CYP2D6KMT2ASLC6A2SLC6A3
SCHEMBL19368263 0.84 CYP1A2 (0.62) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL16982012 0.74 CYP2D6 (0.56) CYP1A2CYP2C19CYP3A4CYP2D6KMT2A
SCHEMBL19976621 0.71 P2RX7 (0.50) CYP2C19CYP3A4CYP2D6TSHRSLC6A2
SCHEMBL5258110 0.70 SLC6A3 (0.45) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL2427658 0.70 SLC6A4 (0.64) CYP1A2CYP2C19CYP3A4CYP2D6KMT2A
SCHEMBL277165 0.70 ALDH1A1 (0.54) CYP1A2CYP2C19HRH3KMT2AMEN1
SCHEMBL28128634 0.69 CYP1A2 (0.45) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL28840472 0.69 CYP1A2 (0.45) CYP1A2CYP2C19CYP3A4CYP2D6TSHR
SCHEMBL847809 0.68 ALDH1A1 (0.57) CYP1A2CYP2C19CYP3A4KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150218110-A1 USE OF SUBSTITUTED BENZODIAZEPINONES AND BENZAZEPINONES OR THE SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2015-08-06 US disclosed
US-20150218110-A1 USE OF SUBSTITUTED BENZODIAZEPINONES AND BENZAZEPINONES OR THE SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2015-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218110-A1 USE OF SUBSTITUTED BENZODIAZEPINONES AND BENZAZEPINONES OR THE SALTS THEREOF AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS GABBR1, GABRA1, GABRA6 CYP1A2 42/4885CYP2C19 28/4885CYP3A4 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.